http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103834673-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-10 |
| filingDate | 2012-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103834673-B |
| titleOfInvention | EXT1 gene mutation bodies and its application |
| abstract | The invention discloses EXT1 gene mutation bodies and its applications, more particularly to the nucleic acid of the coding EXT1 mutant of separation, the polypeptide of separation, the method that screening is susceptible to suffer from the biological sample of the multiple chondroma disease of heredity, the system that screening is susceptible to suffer from the biological sample of the multiple chondroma disease of heredity, the method that kit and screening for screening the biological sample for being susceptible to suffer from the multiple chondroma disease of heredity treat or prevent the drug of the multiple chondroma disease of heredity.Wherein, the nucleic acid of the coding EXT1 mutant of the separation, with SEQ ID NO：1 compares, and is mutated with c.1457 1458insG.It whether there is in the biological sample by detecting the new mutant, can be effectively detected whether biological sample is susceptible to suffer from the multiple chondroma disease of heredity. |
| priorityDate | 2012-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 19.